1. Home
  2. SLNG vs ASMB Comparison

SLNG vs ASMB Comparison

Compare SLNG & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

N/A

Current Price

$5.01

Market Cap

119.0M

Sector

Utilities

ML Signal

N/A

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$25.59

Market Cap

512.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLNG
ASMB
Founded
2013
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
512.1M
IPO Year
2019
2010

Fundamental Metrics

Financial Performance
Metric
SLNG
ASMB
Price
$5.01
$25.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$10.00
$44.20
AVG Volume (30 Days)
41.9K
296.5K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
2400.00
91.78
EPS
N/A
N/A
Revenue
$68,245,000.00
N/A
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
$638.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.21
$20.23
52 Week High
$7.07
$39.71

Technical Indicators

Market Signals
Indicator
SLNG
ASMB
Relative Strength Index (RSI) 42.02 39.48
Support Level $4.95 $25.86
Resistance Level $5.61 $30.62
Average True Range (ATR) 0.51 1.71
MACD -0.17 -0.95
Stochastic Oscillator 3.30 2.07

Price Performance

Historical Comparison
SLNG
ASMB

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: